Which has grown faster, LH or MRNA?

Over the past five years, MRNA grew revenue faster — LH at a -1.58% CAGR versus MRNA at 19.33%.

Does LH or MRNA pay a bigger dividend?

LH pays a dividend (0.92% yield), while MRNA has no payments in the available dividend history.

Is LH or MRNA more profitable?

LH runs the higher net margin — LH at 6.66% versus MRNA at -143.55%.

How have LH and MRNA total returns compared?

Over the past 5 years, LH delivered 10.77% and MRNA delivered -30.71% annualized total return. Past performance doesn't predict future results.

Labcorp Holdings Inc. (LH) vs Moderna, Inc. (MRNA)

A side-by-side comparison of Labcorp Holdings Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.

Labcorp Holdings Inc.

$25.47B

$310.62HealthcareDelayed quote: Jul 29, 2026, 12:25 PM EDT

MRNA

Moderna, Inc.

$21.61B

$54.46HealthcareDelayed quote: Jul 29, 2026, 12:24 PM EDT

Total return — LH vs MRNA

growth of $100 · dividends reinvested · last 8y

LH +137.9%MRNA +200.1%MRNA compounded faster

LH MRNA

LH vs MRNA: by the numbers

•LH is the larger company ($25.47B vs $21.61B market cap).
•LH is profitable (6.66% net margin) while MRNA runs a net loss (-143.55%).
•MRNA grew revenue faster over the past five years (19.33% vs -1.58% CAGR).
•LH pays a dividend (0.92% yield), while MRNA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	LH	MRNA
P/E ratio	27.83	N/A
Forward P/E	17.44	N/A
P/S ratio	1.84	9.91
P/B ratio	2.98	2.98
PEG ratio	1.28	N/A
EV / EBITDA	14.37	N/A
FCF yield	5.31%	N/A

Profitability

Metric	LH	MRNA
Gross margin	27.79%	55.35%
Operating margin	11.03%	-153.35%
Net margin	6.66%	-143.55%
ROE	10.79%	-43.12%
ROIC	7.39%	-29.70%

Dividends

Metric	LH	MRNA
Dividend yield	0.92%	N/A
Payout ratio	27.32%	N/A

Growth (annualized)

Metric	LH	MRNA
Revenue CAGR (5Y)	-1.58%	19.33%
EPS CAGR (5Y)	-8.00%	N/A
FCF CAGR (5Y)	-12.63%	N/A
Total return CAGR (5Y)	6.34%	-30.71%

Frequently asked

Which has grown faster, LH or MRNA?: Over the past five years, MRNA grew revenue faster — LH at a -1.58% CAGR versus MRNA at 19.33%.
Does LH or MRNA pay a bigger dividend?: LH pays a dividend (0.92% yield), while MRNA has no payments in the available dividend history.
Is LH or MRNA more profitable?: LH runs the higher net margin — LH at 6.66% versus MRNA at -143.55%.
How have LH and MRNA total returns compared?: Over the past 5 years, LH delivered 10.77% and MRNA delivered -30.71% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LH analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Labcorp P/E ratio Moderna P/E ratio Labcorp dividend yield Moderna dividend yield Labcorp ROE Moderna ROE Labcorp operating margin Moderna operating margin Labcorp revenue growth Moderna revenue growth Labcorp free cash flow Moderna free cash flow

Labcorp & Moderna appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.